---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-23-000075"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2023-03-23T23:59:59+00:00"
generated_at: "2026-06-17T17:50:36.776144+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions eliminates Chief Strategy role; 2022 bonuses slashed below target

## Summary
- Atul Saran departed as Chief Strategy Officer on March 17, 2023; receives severance per plan and RSU acceleration.
- 2022 NEO bonuses reduced due to below-target performance: CEO at 25%, others at 50% of target.
- Actual annual incentives for NEOs ranged from 25% to 58% of target.
- 2023 base salaries set: CEO $1,032,500 (120% bonus target); CFO $615,000; COO/GC $585,000 each.
- 2023 equity grants limited by share availability; PSUs tied to cumulative revenue and Adjusted EBITDA Margin over 2023-2025.

## SEC filing metadata
- accession: 0001367644-23-000075
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2023-03-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000075/0001367644-23-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000075/ebs-20230323.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-23-000075
- JSON: https://secwatch.observer/filing/0001367644-23-000075.json
- Plain text: https://secwatch.observer/filing/0001367644-23-000075.txt

## Key facts
- Executive change
  Atul Saran departed as Chief Strategy and Development Officer at Emergent BioSolutions Inc..
  - Action: departed
  - Role: Chief Strategy and Development Officer
  source text: On March 17, 2023, in connection with the elimination of his position as Chief Strategy and Development Officer, the Company entered into a Separation Agreement (the “Separation Agreement”) with Atul Saran.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000075/0001367644-23-000075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.